CLINICAL_TRIALS
trial_result
· 2017-10-02
Clinical Trial Update: ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors [Phase 1, Phase 2]
Summary
A Phase 1/2 trial of ME-344 combined with Hycamtin (topotecan) in solid tumors was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MEI Pharma, Inc. | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-10-02